Analyst Round-Up F5 Networks (FFIV): 3 Upgrades & A Litany of Price Target Raises
Get Alerts FFIV Hot Sheet
Price: $384.63 +1.81%
Rating Summary:
21 Buy, 25 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
21 Buy, 25 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
With F5 Networks (Nasdaq: FFIV) reporting strong Q4 results and guiding Q1 above the Street last night (and the resulting 15% rise in the stock today), a flock of analysts jumped on the bandwagon this morning. Amid the scrambling, we've got at least 3 upgrades today, as well as 11 estimate and price target raises.
Below are some of the analyst changes:
Below are some of the analyst changes:
- upgraded from Sell to Neutral at UBS. The firm moved its price target from $29 to $47
- upgraded from Speculative Buy to Buy at Canaccord Adams
- upgraded from Neutral to Buy at MKM Partners. Price target from $36 to $50
- Goldman Sachs - price target moves from $38 to $43, maintains Neutral
- BofA - price target from $45 to $50, maintains Neutral
- Deutsche Bank - price target from $46 to $48, maintains Buy
- Barclays - target from $45 to $51, maintains Overweight
- Piper Jaffray - target from $42 to $51, maintains Overweight
- Wedbush - target from $43 to $50, maintains Neutral
- Thomas Weisel - target from $28 to $42, maintains Market Weight
- RBC Capital - target from $40 to $49, maintains Sector Perform
- BMO Capital - target from $36 to $46, maintains Market Perform
- Broadpoint.AmTech - target from $28 to $37, maintains Neutral
- Boenning & Scattergood - target from $45 to $53, maintains Outperform
You May Also Be Interested In
- SEC accuses ex-BofA senior banker Satsky of insider trading - Bloomberg
- Sky Century Investment responds to OTC Markets stock promotion inquiry
- Kairos Pharma announces 1-for-7 reverse stock split
Create E-mail Alert Related Categories
Analyst Comments, Insiders' Blog, UpgradesRelated Entities
Piper Jaffray, Deutsche Bank, UBS, Canaccord Adams, BMO Capital, RBC Capital, American Technology Research, Barclays, Thomas Weisel Partners Group, Boenning & ScattergoodSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share